Taken together, our study demonstrates that USP39 serves as an oncogenic factor in ESCC through promoting tumor proliferation in vivo and in vitro, improving invasion and migration of cancer cells and inhibiting the cell apoptosis with the treatment of DDP. The gene discussed is USP39; the disease is esophageal squamous cell carcinoma.